PMV Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

Pmv Pharmaceuticals

29/02/2024 21:44

* PMV Pharmaceuticals Inc  PMVP.OQ  reported a quarterly
adjusted
loss of 31 cents​​ per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of -43 cents.  The mean expectation of
five analysts for the quarter was for a loss of 39 cents per
share. Wall Street expected results to range from -43 cents
to -32 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * PMV Pharmaceuticals Inc's reported EPS for the quarter was
a
loss of 31 cents​.
    * The company reported a quarterly loss of $15.09 million.
    * PMV Pharmaceuticals Inc shares had fallen by 41.6% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 5.9%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for PMV
Pharmaceuticals Inc is $7.00 
This summary was machine generated from LSEG data February 29 at
09:43 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.39          -0.31          Beat
 Sep. 30 2023      -0.45          -0.34          Beat
 Jun. 30 2023      -0.47          -0.38          Beat
 Mar. 31 2023      -0.46          -0.42          Beat